319 related articles for article (PubMed ID: 32987135)
1. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
[TBL] [Abstract][Full Text] [Related]
2. Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Patil PS; Kasare SL; Haval NB; Khedkar VM; Dixit PP; Rekha EM; Sriram D; Haval KP
Bioorg Med Chem Lett; 2020 Oct; 30(19):127434. PubMed ID: 32717369
[TBL] [Abstract][Full Text] [Related]
3. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
4. Click chemistry based regioselective one-pot synthesis of coumarin-3-yl-methyl-1,2,3-triazolyl-1,2,4-triazol-3(4H)-ones as newer potent antitubercular agents.
Somagond SM; Kamble RR; Bayannavar PK; Shaikh SKJ; Joshi SD; Kumbar VM; Nesaragi AR; Kariduraganavar MY
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900013. PubMed ID: 31397503
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and molecular docking study of novel triazole-quinazolinone hybrids as antimalarial and antitubercular agents.
Mhetre UV; Haval NB; Bondle GM; Rathod SS; Choudhari PB; Kumari J; Sriram D; Haval KP
Bioorg Med Chem Lett; 2024 Aug; 108():129800. PubMed ID: 38763480
[TBL] [Abstract][Full Text] [Related]
6. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
[TBL] [Abstract][Full Text] [Related]
10. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
11. Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.
Pradeep Kumar CB; Prathibha BS; Prasad KNN; Raghu MS; Prashanth MK; Jayanna BK; Alharthi FA; Chandrasekhar S; Revanasiddappa HD; Yogesh Kumar K
Bioorg Med Chem Lett; 2021 Mar; 36():127810. PubMed ID: 33482292
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2017 Dec; 27(23):5119-5121. PubMed ID: 29113761
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3-Triazoles: A Computational Docking Techniques.
Sadineni K; Reddy Basireddy S; Rao Allaka T; Yatam S; Bhoomandla S; Muvvala V; Babu Haridasyam S
Chem Biodivers; 2024 May; 21(5):e202400389. PubMed ID: 38457745
[TBL] [Abstract][Full Text] [Related]
15. Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.
Altimari JM; Hockey SC; Boshoff HI; Sajid A; Henderson LC
ChemMedChem; 2015 May; 10(5):787-91. PubMed ID: 25788466
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
Kim S; Cho SN; Oh T; Kim P
Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
[TBL] [Abstract][Full Text] [Related]
17. Clubbed triazoles: a novel approach to antitubercular drugs.
Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
[TBL] [Abstract][Full Text] [Related]
18. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
[TBL] [Abstract][Full Text] [Related]
19. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
